Fieldpoint Private Securities’s Chemed CHE Stock Holding History

Fieldpoint Private Securities’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$76K	Sell	161 -69	-30%	-$33.7K	0.02%	407
2022 Q1	$117K	Buy	230 +7	+3%	+$3.36K	0.02%	402
2021 Q4	$118K	Buy	223 +4	+2%	+$1.92K	0.02%	413
2021 Q3	$102K	Buy	219 +13	+6%	+$6.13K	0.02%	410
2021 Q2	$95K	Sell	206 -13	-6%	-$6.24K	0.02%	428
2021 Q1	$101K	Buy	219 +47	+27%	+$23K	0.02%	400
2020 Q4	$92K	Buy	+172	New	+$84.5K	0.02%	412
2020 Q1	–	Sell	-182	Closed	-$80K	–	307
2019 Q4	$80K	Buy	182 +79	+77%	+$33.2K	0.02%	357
2019 Q3	$43K	Buy	103 +42	+69%	+$17.1K	0.02%	404
2019 Q2	$22K	Buy	+61	New	+$20.4K	0.01%	514

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fieldpoint Private Securities's CHE Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Chemed (CHE) stake by 30% in Q2 2022, selling an estimated $33.7K and leaving 161 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #407.

Fieldpoint Private Securities first reported a position in CHE in Q2 2019 and has held it in 10 quarters since. The position peaked at $118K in Q4 2021. 429 funds tracked by Wall St. Rank hold CHE as of Q2 2022.

Fieldpoint Private Securities held 161 shares of Chemed worth $76K as of Q2 2022.
Fieldpoint Private Securities sold 69 Chemed shares in Q2 2022, an estimated $33.7K.
Chemed made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #407 holding.
Fieldpoint Private Securities first reported a position in Chemed in Q2 2019 and has held it in 10 quarters since.
Fieldpoint Private Securities's Chemed position peaked at $118K in Q4 2021.
429 funds tracked by Wall St. Rank held Chemed as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.